In January, a federal jury convicted Holmes of four counts of fraud, including an investor wire fraud conspiracy count and three substantive wire fraud counts, with wire transfers totaling more than $140 million.
After a key witness arrived at Holmes' house in August and expressed regrets about his role in the trial, a California judge has decided to grant Holmes a chance for a new trial.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A former Theranos lab director who testified during Elizabeth Holmes' trial said he's had trouble sleeping because of regrets about the trial and showed up at her door "disheveled" and wanting to talk.
A partially redacted document filed in federal court last week in connection with the trial stated that Holmes planned to obtain an evaluation from a psychologist. The court allowed federal prosecutors to obtain an evaluation from their own experts as well.
Theranos whistleblowers Erika Cheung and Tyler Shultz have established an organization called Ethics in Entrepreneurship hoping to prevent other tech and health startups and employees from going through what they did.
Various news outlets reported that attorneys for Holmes successfully convinced a federal judge to delay setting a trial date in order to get more time to review some 20 million pages of documents.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Despite a couple of flaws, Alex Gibney's new film - airing March 18 - expertly portrays how Elizabeth Holmes's dream of changing the world of lab testing became a fraud.
Peer review is important for ensuring transparency and trust and may have put a stop to Theranos before it became a darling of investors and the press, the lead study author said in an interview.
Healthcare VCs provided their thoughts on why startups die, followed by a roundup of five companies that didn't survive 2018.
During an event Rock Health Summit in San Francisco, the always quotable Cosgrove shared his thoughts on topics ranging from the V.A. to Theranos to EMRs to where he believed big tech firms can hope to change healthcare.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The company is negotiating with creditor Fortress to keep $5 million that it will distribute to creditors, to whom it owes $60 million.
The criminal trial of Theranos CEO Elizabeth Holmes will help entrepreneurs see the legal ramifications of hyping and under-delivering presumed medical advances and ultimately be good for innovation.
Federal prosecutors from the U.S. attorney’s office in San Francisco have charged Holmes and COO Sunny Balwani with fraud over allegedly lying to investors and misleading doctors and patients about their technology and its accuracy, according to The Wall Street Journal.
Tim Draper, the founder of Draper Associates and one of the earliest backers of Theranos, appeared to be in denial about the true cause of the company's downfall in an interview on CNBC Thursday.
The diagnostics company has cut back most of its staff from more than 100 employees to about two dozen in the wake of a civil fraud complaint from the SEC last month, according to The Wall Street Journal.